Total Payments
$94,961
2024 Payments
$17,193
Companies
52
Transactions
762
Medicare Patients
2,679
Medicare Billing
$333,305
Payment Breakdown by Category
Other$74,550 (78.5%)
Food & Beverage$13,983 (14.7%)
Travel$6,352 (6.7%)
Education$75.71 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $74,550 | 28 | 78.5% |
| Food and Beverage | $13,983 | 714 | 14.7% |
| Travel and Lodging | $6,352 | 12 | 6.7% |
| Education | $75.71 | 4 | 0.1% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$94,961
758 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $86,985 | 315 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $821.83 | 71 | $0 (2024) |
| PFIZER INC. | $809.75 | 55 | $0 (2024) |
| Celgene Corporation | $807.52 | 37 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $684.50 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $680.96 | 56 | $0 (2024) |
| Gilead Sciences, Inc. | $635.41 | 48 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $312.33 | 16 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $268.42 | 20 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $230.73 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,193 | 110 | ABBVIE INC. ($16,016) |
| 2023 | $22,223 | 96 | ABBVIE INC. ($20,889) |
| 2022 | $13,186 | 74 | ABBVIE INC. ($12,479) |
| 2021 | $18,756 | 132 | AbbVie Inc. ($17,460) |
| 2020 | $14,457 | 69 | AbbVie Inc. ($13,986) |
| 2019 | $6,429 | 84 | AbbVie, Inc. ($5,473) |
| 2018 | $1,247 | 87 | AbbVie, Inc. ($274.95) |
| 2017 | $1,470 | 110 | AbbVie, Inc. ($405.62) |
All Payment Transactions
762 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $1,444.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $93.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: LIVER DISEASE | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $418.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $76.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $64.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: VIROLOGY | ||||||
| 10/30/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.32 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/24/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $101.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 554 | 581 | $385,106 | $73,162 |
| 2022 | 15 | 673 | 721 | $404,744 | $76,456 |
| 2021 | 17 | 773 | 818 | $464,699 | $100,811 |
| 2020 | 17 | 679 | 729 | $380,476 | $82,876 |
Total Patients
2,679
Total Services
2,849
Medicare Billing
$333,305
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 116 | 116 | $135,836 | $20,696 | 15.2% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 21 | 21 | $46,200 | $11,757 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 121 | $19,360 | $7,549 | 39.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 42 | 42 | $33,726 | $7,439 | 22.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 48 | 48 | $42,384 | $4,438 | 10.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 24 | 24 | $19,632 | $4,308 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 47 | $11,045 | $4,164 | 37.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 51 | 51 | $30,192 | $3,458 | 11.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $9,165 | $3,061 | 33.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $17,996 | $2,775 | 15.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $13,225 | $1,614 | 12.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,110 | $1,375 | 26.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 13 | $1,235 | $530.95 | 43.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 108 | 108 | $126,468 | $20,564 | 16.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 55 | 55 | $44,165 | $9,941 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 154 | $24,640 | $9,594 | 38.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 70 | 70 | $61,810 | $7,849 | 12.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 61 | $14,335 | $5,660 | 39.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 70 | 72 | $42,624 | $5,084 | 11.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 23 | 23 | $18,814 | $4,198 | 22.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $20,450 | $3,308 | 16.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 42 | 42 | $9,870 | $3,237 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $7,665 | $2,421 | 31.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 29 | 30 | $17,250 | $1,683 | 9.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 16 | 17 | $11,798 | $1,448 | 12.3% |
About Dr. Pradeep Kumar, M.D
Dr. Pradeep Kumar, M.D is a Gastroenterology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093790537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pradeep Kumar, M.D has received a total of $94,961 in payments from pharmaceutical and medical device companies, with $17,193 received in 2024. These payments were reported across 762 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($74,550).
As a Medicare-enrolled provider, Kumar has provided services to 2,679 Medicare beneficiaries, totaling 2,849 services with total Medicare billing of $333,305. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Austin, TX
- Active Since 12/07/2005
- Last Updated 11/13/2009
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1093790537
Products in Payments
- HUMIRA (Biological) $28,201
- SKYRIZI (Biological) $26,983
- RINVOQ (Biological) $16,334
- STELARA (Biological) $1,226
- ZEPOSIA (Drug) $794.13
- XELJANZ (Drug) $764.97
- XIFAXAN (Drug) $706.87
- Humira (Biological) $568.59
- ZENPEP (Drug) $377.14
- MAVYRET (Drug) $356.32
- LINZESS (Drug) $327.83
- CREON (Drug) $289.93
- Mavyret (Drug) $234.15
- DUPIXENT (Biological) $186.36
- INJECTAFER (Drug) $167.63
- XARELTO (Drug) $142.42
- Amitiza (Drug) $140.19
- OCALIVA (Drug) $136.08
- Linzess (Drug) $132.20
- Cologuard Collection Kit (Device) $130.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Austin
Dr. Harish Gagneja, Md, MD
Gastroenterology — Payments: $760,415
Gastroenterology $760,415
Harry Thomas, Md, MD
Gastroenterology — Payments: $360,300
Gastroenterology $360,300
Dr. Jianhua Tau, M.d, M.D
Gastroenterology — Payments: $90,140
Gastroenterology $90,140
Dr. Scott Becker, M.d, M.D
Gastroenterology — Payments: $46,704
Gastroenterology $46,704
Binh Pham, M.d, M.D
Gastroenterology — Payments: $37,217
Gastroenterology $37,217
Dr. Benjamin Havemann, M.d, M.D
Gastroenterology — Payments: $36,638
Gastroenterology $36,638